Medtronic PLC (MDT)
Financial leverage ratio
Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | Apr 30, 2022 | ||
---|---|---|---|---|---|---|
Total assets | US$ in thousands | 89,981,000 | 89,981,000 | 90,948,000 | 90,948,000 | 90,981,000 |
Total stockholders’ equity | US$ in thousands | 50,214,000 | 50,214,000 | 51,483,000 | 51,483,000 | 52,551,000 |
Financial leverage ratio | 1.79 | 1.79 | 1.77 | 1.77 | 1.73 |
April 30, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $89,981,000K ÷ $50,214,000K
= 1.79
The financial leverage ratio of Medtronic PLC shows a slight increase over the period from April 30, 2022, to April 30, 2024. The ratio stood at 1.73 on April 30, 2022, and gradually increased to 1.79 by April 30, 2024. This indicates that the company's reliance on debt to finance its operations has slightly increased over the period. It is important for investors and stakeholders to monitor this trend as higher leverage ratios could indicate increased financial risk for the company.
Peer comparison
Apr 30, 2024
Company name
Symbol
Financial leverage ratio
Medtronic PLC
MDT
1.79
BioLife Solutions Inc
BLFS
1.14
CONMED Corporation
CNMD
2.40
LivaNova PLC
LIVN
1.90
Masimo Corporation
MASI
2.50
TransMedics Group Inc
TMDX
3.52